-
Case study backs Argent’s cannabinoid for epilepsy
04 Aug 2025 23:59 GMT
… proprietary cannabinoid therapy CannEpil in treatment-resistant epilepsy.
The article titled Management … Food and Drug Administration (FDA) approved cannabinoid treatment for LGS.
The … ."
This article was developed in collaboration with Argent BioPharma …
-
Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures
04 Aug 2025 17:48 GMT
… of the background medication to manage AEs; … and Drug Administration (FDA) granted Breakthrough Therapy … developmental and epileptic encephalopathies (DEEs). The EMBOLD cohort 2 pivotal trial … article Praxis' Epilepsy Treatment Shows Promise With Decreased …
-
‘We had no idea our son was at risk’: readers on living with epilepsy
04 Aug 2025 12:40 GMT
… diagnosis, effective treatment and public awareness of late-onset epilepsy in fit … everyday issues are with the medication. They make the sufferer … are epileptic. The elder developed it later in life after … constantly put on different drugs as they tried to …
-
Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy
04 Aug 2025 11:30 GMT
… to advance into clinical trials those therapeutics with compelling … epilepsy and experience life-long seizures1. Current therapies, including antiepileptic drugs … company focused on developing novel, investigational treatments, including simufilam, …
-
Glymphatic System Dysfunction in Elderly Patients with Late-Onset Epilepsy and Comorbid Chronic Insomnia Revealed by Diffusion Tensor Imaging Along the Perivascular Space (DTI-ALPS)
04 Aug 2025 05:53 GMT
… is excerpted from the MMSE developed by Marshal Folstein and Susan … al. The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol … anti-seizure medication response in patients with temporal lobe epilepsy. Epilepsia Open …
-
In Neurelis v. Brenner, The FDA’s “Indication-Specific” View of Orphan Exclusivity is (Again) Struck Down
02 Aug 2025 06:08 GMT
… , Inc. (“Aquestive”), both developed novel versions of diazepam to … in January 2020, for “treatment of intermittent, stereotypic episodes of … with epilepsy 6 years of age and older.” The FDA … treatment of acute seizures in patients 12 years and older. The FDA …
-
Vietnam Reaches Medical Milestone With First Robotic Brain Surgery on Child with Drug-Resistant Epilepsy
01 Aug 2025 22:33 GMT
… suffered from epilepsy since 2021. Despite undergoing multiple treatment regimens across Vietnam … been searching for a definitive treatment.
That breakthrough came in 2025 … robotic epilepsy surgery also reflects Vinmec's broader strategy of developing …
-
Lorazepam oral tablet interactions: Alcohol, medications, and other factors
01 Aug 2025 20:40 GMT
… Lorazepam is FDA approved as a short-term treatment for … insomnia treatment.)
If taking lorazepam and a medication for … develop symptoms of CNS depression if you take this combination of drugs … prescribe a treatment other than lorazepam.
Epilepsy or seizures …
-
Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
31 Jul 2025 11:30 GMT
… company focused on developing innovative treatments for Alzheimer… Phase IIb/III treatment trial followed the 48-week … and patient friendly oral pill administration option to … additional CNS disorders, including epilepsy. The Michael J. …
-
‘Combat cocktail’: How America overmedicates veterans
01 Aug 2025 03:32 GMT
… system drugs, including antipsychotics, antidepressants and epilepsy medications, sometimes … weight soared and he developed diabetes. Quitting Seroquel … often exploring unconventional treatments. Many veterans said … unproven in clinical trials.
Says Griffin, …